Trade Veracyte Inc - VCYT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 40.98 |
| Open | 41 |
| 1-Year Change | 64.59% |
| Day's Range | 38.42 - 41 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 39.11 | -2.45 | -5.90% | 41.56 | 41.62 | 38.36 |
| Feb 20, 2025 | 40.98 | -0.77 | -1.84% | 41.75 | 41.92 | 40.35 |
| Feb 19, 2025 | 42.06 | 2.05 | 5.12% | 40.01 | 42.16 | 40.01 |
| Feb 18, 2025 | 40.35 | -1.11 | -2.68% | 41.46 | 42.17 | 40.26 |
| Feb 14, 2025 | 41.05 | 1.48 | 3.74% | 39.57 | 41.49 | 39.57 |
| Feb 13, 2025 | 39.54 | -0.95 | -2.35% | 40.49 | 40.82 | 39.37 |
| Feb 12, 2025 | 40.25 | 0.30 | 0.75% | 39.95 | 40.92 | 39.38 |
| Feb 11, 2025 | 40.91 | -0.40 | -0.97% | 41.31 | 41.81 | 40.09 |
| Feb 10, 2025 | 41.90 | 0.34 | 0.82% | 41.56 | 42.16 | 40.54 |
| Feb 7, 2025 | 41.48 | -1.64 | -3.80% | 43.12 | 43.31 | 40.39 |
| Feb 6, 2025 | 43.45 | -2.10 | -4.61% | 45.55 | 45.96 | 43.27 |
| Feb 5, 2025 | 45.15 | 1.45 | 3.32% | 43.70 | 45.26 | 43.70 |
| Feb 4, 2025 | 43.69 | -1.03 | -2.30% | 44.72 | 45.42 | 43.58 |
| Feb 3, 2025 | 44.99 | 1.84 | 4.26% | 43.15 | 45.71 | 42.98 |
| Jan 31, 2025 | 45.37 | -0.78 | -1.69% | 46.15 | 46.15 | 45.06 |
| Jan 30, 2025 | 46.07 | 0.99 | 2.20% | 45.08 | 47.06 | 45.08 |
| Jan 29, 2025 | 44.39 | 0.14 | 0.32% | 44.25 | 45.24 | 43.11 |
| Jan 28, 2025 | 43.63 | 0.73 | 1.70% | 42.90 | 44.15 | 42.49 |
| Jan 27, 2025 | 42.92 | 0.66 | 1.56% | 42.26 | 43.35 | 41.95 |
| Jan 24, 2025 | 43.74 | 0.50 | 1.16% | 43.24 | 44.80 | 43.21 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Veracyte Inc Company profile
About Veracyte Inc
Veracyte, Inc. is a genomic diagnostics company. The Company offers customized biomarker testing and analytical services. It offers a complete range of in vitro diagnostic (IVD) and companion diagnostic development services to biopharmaceutical companies and diagnostic companies. It offers tests across various diseases, which include Afirma Genomic Sequencing Classifier for thyroid cancer; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer; Prosigna Breast Cancer Assay for breast cancer; Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer; Envisia Genomic Classifier test for interstitial lung diseases; Decipher Bladder Genomic Classifier test for bladder cancer and Immunoscore Colon Cancer Test for colon cancer. It also offers Immunogram, a spatial molecular analysis and bioinformatics tool that integrates genomic, transcriptomic and proteomic data to help researchers understand the intricacies of the tumor immune microenvironment.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Veracyte Inc revenues increased 87% to $219.5M. Net loss increased from $34.9M to $75.6M. Revenues reflect United States segment increase of 83% to $201M, International segment increase from $7.9M to $18.5M. Higher net loss reflects Selling and marketing - Balancing value increase of 54% to $75.4M (expense), General & Administrative Expenses increase of 47% to $42.2M (expense).
Equity composition
Common Stock, $0.001 Par, 10/13, 125M auth., 20,989,890 issd., Insiders Own 76.17%
| Industry: | Bio Diagnostics & Testing |
6000 Shoreline Court, Suite 300
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com